BioNxt Solutions Inc. (BNXT.CN)
CAD 0.32
(1.61%)
CAD 0.32
(1.61%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 6.73 Million CAD | 8.32% |
| 2022 | 6.24 Million CAD | -62.2% |
| 2021 | 16.5 Million CAD | 8.98% |
| 2020 | 15.14 Million CAD | 106.83% |
| 2019 | 7.32 Million CAD | 743.85% |
| 2018 | 867.96 Thousand CAD | 19252.71% |
| 2017 | 4485.00 CAD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q2 | 713.98 Thousand CAD | -45.18% |
| 2024 Q1 | 1.33 Million CAD | -33.42% |
| 2023 Q1 | 1.49 Million CAD | -18.38% |
| 2023 Q4 | 1.99 Million CAD | 83.51% |
| 2023 FY | 6.75 Million CAD | 8.32% |
| 2023 Q2 | 2.13 Million CAD | 42.48% |
| 2023 Q3 | 1.08 Million CAD | -48.85% |
| 2022 Q2 | 1.73 Million CAD | 17.22% |
| 2022 FY | 6.24 Million CAD | -62.2% |
| 2022 Q4 | 1.83 Million CAD | 52.48% |
| 2022 Q1 | 1.47 Million CAD | -69.53% |
| 2022 Q3 | 1.2 Million CAD | -30.58% |
| 2021 Q2 | 3.98 Million CAD | -23.77% |
| 2021 Q1 | 5.22 Million CAD | 76.87% |
| 2021 Q3 | 2.45 Million CAD | -38.31% |
| 2021 Q4 | 4.84 Million CAD | 97.21% |
| 2021 FY | 16.5 Million CAD | 8.98% |
| 2020 Q4 | 2.95 Million CAD | -40.1% |
| 2020 Q2 | 3.48 Million CAD | -7.96% |
| 2020 Q1 | 3.78 Million CAD | 98.81% |
| 2020 FY | 15.14 Million CAD | 106.83% |
| 2020 Q3 | 4.93 Million CAD | 41.63% |
| 2019 Q4 | 1.9 Million CAD | -49.53% |
| 2019 FY | 7.32 Million CAD | 743.85% |
| 2019 Q3 | 3.76 Million CAD | 128.21% |
| 2019 Q2 | 1.65 Million CAD | 116.12% |
| 2019 Q1 | 764.34 Thousand CAD | 50.33% |
| 2018 Q1 | 83.72 Thousand CAD | 0.0% |
| 2018 Q2 | 276.32 Thousand CAD | 230.05% |
| 2018 FY | 867.96 Thousand CAD | 19252.71% |
| 2018 Q4 | 508.45 Thousand CAD | 510.62% |
| 2018 Q3 | 83.26 Thousand CAD | -69.87% |
| 2017 FY | 4485.00 CAD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Aion Therapeutic Inc. | 163.11 Thousand CAD | -4031.731% |
| Ayurcann Holdings Corp. | 11.71 Million CAD | 42.477% |
| Blueberries Medical Corp. | 84.22 Thousand CAD | -7901.847% |
| The BC Bud Corporation | 1.28 Million CAD | -425.304% |
| CordovaCann Corp. | 3.86 Million CAD | -74.528% |
| Christina Lake Cannabis Corp. | 4.28 Million CAD | -57.35% |
| Captor Capital Corp. | 16.28 Million CAD | 58.608% |
| City View Green Holdings Inc. | 705.7 Thousand CAD | -855.005% |
| 1CM Inc. | 7.3 Million CAD | 7.777% |
| Global Hemp Group Inc. | 551.7 Thousand CAD | -1121.58% |
| Greenway Greenhouse Cannabis Corporation | 4.8 Million CAD | -40.185% |
| IM Cannabis Corp. | 22.63 Million CAD | 70.229% |
| Lobe Sciences Ltd. | 4.13 Million CAD | -63.098% |
| Maple Leaf Green World Inc. | 392.21 Thousand CAD | -1618.328% |
| Mountain Valley MD Holdings Inc. | 60 Thousand CAD | -11132.593% |
| Nextleaf Solutions Ltd. | 1.76 Million CAD | -281.194% |
| Ovation Science Inc. | 54.1 Thousand CAD | -12357.59% |
| Pharmadrug Inc. | 1.33 Million CAD | -404.831% |
| Captiva Verde Wellness Corp. | 1.3 Million CAD | -416.28% |
| RAMM Pharma Corp. | 7.48 Million CAD | 9.904% |
| RIV Capital Inc. | 21.1 Million CAD | 68.063% |
| Revive Therapeutics Ltd. | 3.28 Million CAD | -105.117% |
| Red White & Bloom Brands Inc. | 37.75 Million CAD | 82.151% |
| SLANG Worldwide Inc. | 24.6 Million CAD | 72.61% |
| 1933 Industries Inc. | 5.12 Million CAD | -31.497% |
| Red Light Holland Corp. | 2.02 Million CAD | -233.564% |
| Top Strike Resources Corp. | 3.63 Million CAD | -85.573% |
| Xebra Brands Ltd. | -308.42 Thousand CAD | 2285.174% |
| Adastra Holdings Ltd. | 9.36 Million CAD | 28.001% |